FERHANOĞLU, A. B. Et Al. 2019. Long-term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-center Real-life Experience. 6th Aegean Hematology Oncology Symposium .

FERHANOĞLU, A. B., ÖZBALAK, M. M., Salihoğlu, A., SOYSAL, T., Karadogan, İ., PAYDAŞ, S., ... Özdemir, E.(2019). Long-term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-center Real-life Experience . 6th Aegean Hematology Oncology Symposium

FERHANOĞLU, AHMET Et Al. "Long-term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-center Real-life Experience," 6th Aegean Hematology Oncology Symposium, 2019

FERHANOĞLU, AHMET B. Et Al. "Long-term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-center Real-life Experience." 6th Aegean Hematology Oncology Symposium , 2019

FERHANOĞLU, A. B. Et Al. (2019) . "Long-term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-center Real-life Experience." 6th Aegean Hematology Oncology Symposium .

@conferencepaper{conferencepaper, author={AHMET BURHAN FERHANOĞLU Et Al. }, title={Long-term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-center Real-life Experience}, congress name={6th Aegean Hematology Oncology Symposium}, city={}, country={}, year={2019}}